About the CentriMag Acute Circulatory Support System
Excellent hemocompatibility and unparalleled versatility for optimized patient care.
The CentriMag™ System is the only acute circulatory support system approved for 30-day LVAD, RVAD and BiVAD support. It offers freedom of choice and fits seamlessly into custom circuit designs, and can be used with a variety of cannulation options.
Addressing the broadest spectrum of clinical challenges
The CentriMag blood pump functions as:
Part of an ECMO†† circuit for periods > 6 hours
Extracorporeal bypass circuit for periods up to 30 days*, to support the left, right, or both ventricles of the heart
Optimal Patient Care for a Variety of Applications
Designed for Optimal Hemocompatibility1,2
Driven by Full MagLev™ Flow Technology, the CentriMag and PediMag Pumps include a free-floating magnetically levitated rotor for a contact-free environment. This innovative technology results in excellent hemodynamics, which can lead to minimized blood stagnation, friction and shear stress.3,4
*PMA approval for 30-day use of CentriMag System components include: CentriMag™ Pump, CentriMag™ Console, CentriMag™ Motor, Mag Monitor, Flow Probe, and CentriMag™ Drainage Cannula and CentriMag™ Return Cannula. Optional accessories include: CentriMag™ System Cart, CentriMag™ System Transporter and Pressure Transducer. PMA approval for 30-day use of CentriMag™ System excludes: PediMag™ Blood Pump and any other pediatric components or accessories.
† Approved for 30-day use
†† COVID-19 Temporary Expanded Indication under US FDA enforcement policy guidance
References
John, R., Liao, K., Lietz, K., Kamdar, F., Colvin-Adams, M., Boyle, A., … Joyce, Lyle. (2007). Experience with the Levitronix CentriMag circulatory support system as a bridge to decision in patients with refractory acute cardiogenic shock and multisystem organ failure. The Journal of Thoracic and Cardiovascular Surgery, 134(2), 351-358. https://dx.doi.org/10.1016/j.jtcvs.2007.01.085
John, R., Long, J. W., Massey, H. T., Griffith, B. P., Sun, B. C., Tector, A. J., … Joyce, L. D. (2011). Outcomes of a multicenter trial of the Levitronix CentriMag ventricular assist system for short-term circulatory support. The Journal of Thoracic and Cardiovascular Surgery, 141(4), 932-939. https://dx.doi.org/10.1016/j.jtcvs.2010.03.046
Aziz, T. A., Singh, G., Popjes, E., Stephenson, E., Mulvey, S., Pae, W., & El-Banayosy, A. (2010). Initial experience with CentriMag extracorporeal membrane oxygenation for support of critically ill patients with refractory cardiogenic shock. The Journal of Heart and Lung Transplantation, 29(1), 66-71. https://dx.doi.org/10.1016/j.healun.2009.08.025
Bhama, J. K., Kornos, R. L., Toyoda, Y., Teuteberg, J. J., McCurry, K. R., & Siegenthaler, M. P. (2009). Clinical experience using the Levitronix CentriMag system for temporary right ventricular mechanical circulatory support. The Journal of Heart and Lung Transformation, 28(9), 971-976. https://www.jhltonline.org/article/S1053-2498(09)00238-1/fulltext
Takeda K, Garan AR, Ando M, et al. Minimally invasive CentriMag ventricular assist device support integrated with extracorporeal membrane oxygenation in cardiogenic shock patients: a comparison with conventional CentriMag biventricular support configuration. Eur J Cardio-Thorac Surg. 2017;52:1055-1061.
Worku B, Pak S-W, van Patten D, et al. The CentriMag ventricular assist device in acute heart failure refractory to medical management. J Heart Lung Transplant. 2012;31:611-617.
Takayama H, Soni L, Kalesan B, et al. Bridge-to-decision therapy with a continuous-flow external ventricular assist device in refractory cardiogenic shock of various causes. Circ Heart Fail. 2014;7:799-806.
Please Enter the Pop Up text to be displayed in Pop Up here.
MAT-2207132 v2.0
DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?
CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.
Precautions
Please be sure to read it.
The following pages are intended for medical professionals and provide information on the proper use of products (medical devices, etc.) of Abbott Medical Japan GK.
The information provided here is not intended to provide information to patients and the general public.
Are you a healthcare professional?
Test
yes
Precautions
Please be sure to read it.
The following pages are intended for medical professionals and provide information on the proper use of products (medical devices, etc.) of Abbott Medical Japan GK.
The information provided here is not intended to provide information to patients and the general public.
Are you a healthcare professional?
Test
[prod, crx3, samplecontent, publish, crx3tar]
test
DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?
CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.
Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
The following pages are intended for medical professionals and provide information on the proper use of products (medical devices, etc.) of Abbott Medical Japan GK.
The information provided here is not intended to provide information to patients and the general public.
